{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:57:29Z","timestamp":1790474249869,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T00:00:00Z","timestamp":1115078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s00296-005-0612-z","type":"journal-article","created":{"date-parts":[[2005,5,2]],"date-time":"2005-05-02T07:22:54Z","timestamp":1115018574000},"page":"452-456","source":"Crossref","is-referenced-by-count":28,"title":["Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Mustafa","family":"Calis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz","family":"Ates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cevat","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kader","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kirnap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Borlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Evereklioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,3]]},"reference":[{"key":"612_CR1","first-page":"1152","volume":"105","author":"H Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et H (1937) Uber rezidivivierende Aphthose, durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152\u20131157","journal-title":"Dermatol Wochenschr"},{"key":"612_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(99)70523-2","volume":"40","author":"JV Ghate","year":"1999","unstructured":"Ghate JV, Jorizzo JL (1999) Beh\u00e7et\u2019s disease and complex aphthosis. J Am Acad Dermatol 40:1\u201318","journal-title":"J Am Acad Dermatol"},{"key":"612_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1517\/14656566.5.2.317","volume":"5","author":"C Evereklioglu","year":"2004","unstructured":"Evereklioglu C (2004) Managing the symptoms of Beh\u00e7et\u2019s disease. Expert Opin Pharmacother 5:317\u2013328","journal-title":"Expert Opin Pharmacother"},{"key":"612_CR4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000051544","volume":"201","author":"C Evereklioglu","year":"2000","unstructured":"Evereklioglu C, Yurekli M, Er H, Ozbek E, Hazneci E, \u00c7ekmen M (2000) Increased plasma adrenomedullin levels in patients with Beh\u00e7et\u2019s disease. Dermatology 201:312\u2013315","journal-title":"Dermatology"},{"key":"612_CR5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2133.2002.04703.x","volume":"147","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Inaloz HS, Kirtak N, Doganay S, Bulbul M, Ozerol E, Er H, Ozbek E (2002) Serum leptin concentration is increased in patients with Beh\u00e7et\u2019s syndrome and is correlated with disease activity. Br J Dermatol 147:331\u2013336","journal-title":"Br J Dermatol"},{"key":"612_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","volume":"11","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-\u03b1, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et\u2019s disease. Mediators Inflamm 11:87\u201393","journal-title":"Mediators Inflamm"},{"key":"612_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1067\/mjd.2002.118338","volume":"46","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M (2002) Increased nitric oxide production in patients with Beh\u00e7et\u2019s disease: is it a new activity marker? J Am Acad Dermatol 46:50\u201354","journal-title":"J Am Acad Dermatol"},{"key":"612_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00002281-200101000-00004","volume":"13","author":"H Yazici","year":"2001","unstructured":"Yazici H, Yurdakul S, Hamuryudan V (2001) Beh\u00e7et\u2019s disease. Curr Opin Rheumatol 13:18\u201322","journal-title":"Curr Opin Rheumatol"},{"key":"612_CR9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/clinchem\/38.7.1322","volume":"38","author":"JPJ Ungerer","year":"1992","unstructured":"Ungerer JPJ, Oosthnizen HM, Bissbort SH, Vermaak WJH (1992) Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem 38:1322\u20131326","journal-title":"Clin Chem"},{"key":"612_CR10","first-page":"763","volume":"43","author":"FJ Al-Shammary","year":"1997","unstructured":"Al-Shammary FJ (1997) Adenosine deaminase activity in serum and pleural effusions of tuberculous and non-tuberculous patients. Biochem Mol Biol Int 43:763\u2013769","journal-title":"Biochem Mol Biol Int"},{"key":"612_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2141.1977.tb08825.x","volume":"37","author":"J Sullivan","year":"1977","unstructured":"Sullivan J, Osborne WR, Wedgewood RJ (1977) Adenosine deaminase activity in lymphocytes. Br J Haematol 37:157\u2013158","journal-title":"Br J Haematol"},{"key":"612_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0009-9120(01)00190-4","volume":"34","author":"K Kose","year":"2001","unstructured":"Kose K, Yazici C, Asc\u0131oglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Beh\u00e7et\u2019s disease. Clin Biochem 34:125\u2013129","journal-title":"Clin Biochem"},{"key":"612_CR13","first-page":"1078","volume":"335","author":"International","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"612_CR14","first-page":"315","volume-title":"Methods of enzymatic analysis","author":"G Giusti","year":"1984","unstructured":"Giusti G, Galanti B (1984) Colorimetric method. In: Bargmeyer HU (ed) Methods of enzymatic analysis. Verlag Chemie, Weinheim, pp 315\u2013323"},{"key":"612_CR15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/112067210201200105","volume":"12","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Er H (2002) Increased corneal thickness in active Beh\u00e7et\u2019s disease. Eur J Ophthalmol 12:24\u201329","journal-title":"Eur J Ophthalmol"},{"key":"612_CR16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1258\/0022215011908946","volume":"115","author":"C Evereklioglu","year":"2001","unstructured":"Evereklioglu C, Cokkeser Y, Doganay S, Er H, Kizilay A (2001) Audio-vestibular evaluation in patients with Beh\u00e7et\u2019s syndrome. J Laryngol Otol 115:704\u2013708","journal-title":"J Laryngol Otol"},{"key":"612_CR17","first-page":"6","volume":"19","author":"A Gul","year":"2001","unstructured":"Gul A (2001) Beh\u00e7et\u2019s disease: an update on the pathogenesis. Clin Exp Rheumatol 19:6\u201312","journal-title":"Clin Exp Rheumatol"},{"key":"612_CR18","first-page":"291","volume-title":"Intermittent and periodic arthritic syndromes in arthritis and allied conditions","author":"DL Kastner","year":"1997","unstructured":"Kastner DL (1997) Intermittent and periodic arthritic syndromes in arthritis and allied conditions, 13th edn. William J. Kopman Williams and Wilkins, Pennsylvania, USA, pp 1291\u20131297","edition":"13th edn"},{"key":"612_CR19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.1997.274-ce1159.x","volume":"107","author":"N Yamashita","year":"1997","unstructured":"Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, Kogure M, Inaba G, Sakane T (1997) Role of gamma delta T lymphocytes in the development of Beh\u00e7et\u2019s disease. Clin Exp Immunol 107:241\u2013247","journal-title":"Clin Exp Immunol"},{"key":"612_CR20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1378\/chest.97.3.605","volume":"97","author":"MF Baganha","year":"1990","unstructured":"Baganha MF, Pego A, Maria A, Lima MA, Gaspar EV, Cordeiro AR (1990) Serum and pleural adenosine deaminase: correlation with lymphocytic populations. Chest 97:605\u2013610","journal-title":"Chest"},{"key":"612_CR21","first-page":"583","volume":"16","author":"M Stancikova","year":"1998","unstructured":"Stancikova M, Lukac J, Istok R, Cristalli G, Rovensky J (1998) Serum adenosine deaminase activity and its isoenzyme pattern in patients with systemic lupus erythematosus. Clin Exp Rheumatol 16:583\u2013586","journal-title":"Clin Exp Rheumatol"},{"key":"612_CR22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s100670170005","volume":"20","author":"S Hitoglou","year":"2001","unstructured":"Hitoglou S, Hatzistilianou M, Gougoustamou D, Athanassiadou F, Kotsis A, Catriu D (2001) Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 20:411\u2013416","journal-title":"Clin Rheumatol"},{"key":"612_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2340\/0001555575297299","volume":"75","author":"P Meunier","year":"1995","unstructured":"Meunier P, Filipe P, Emerit I, Freitas J, Guerra Rodrigo F, Adenosine MC (1995) Deaminase in progressive systemic sclerosis. Acta Dermatol Venereol 75:297\u2013299","journal-title":"Acta Dermatol Venereol"},{"key":"612_CR24","first-page":"97","volume":"13","author":"FA Gener","year":"1998","unstructured":"Gener FA, Turkozkan N, Sever A (1998) The levels of adenosine deaminase activity in knee effusions. Turk J Biochem 13:97\u2013101","journal-title":"Turk J Biochem"},{"key":"612_CR25","first-page":"87","volume":"21","author":"RA Sari","year":"2003","unstructured":"Sari RA, Taysi S, Yilmaz O, Bakan N (2003) Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol 21:87\u201390","journal-title":"Clin Exp Rheumatol"},{"key":"612_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/0962935031000097754","volume":"12","author":"K Erkilic","year":"2003","unstructured":"Erkilic K, Evereklioglu C, Cekmen M, Ozkiris A, Duygulu F, Dogan H (2003) Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Beh\u00e7et\u2019s disease: original contributions\/clinical and laboratory investigations. Mediators Inflamm 12:107\u2013116","journal-title":"Mediators Inflamm"},{"key":"612_CR27","first-page":"287","volume":"98","author":"R Fukami","year":"1994","unstructured":"Fukami R, Ohba S, Ishida K, Nakamura S, Konno M, Ohno S (1994) Serum adenosine deaminase and angiotensin converting enzyme activity in patients with endogenous uveitis. Nippon Ganka Gakkai Zasshi 98:287\u2013292","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"612_CR28","first-page":"1094","volume":"128","author":"D Mikulikova","year":"1989","unstructured":"Mikulikova D, Lukac J, Ondrasik M (1989) The effect of colchicine and its derivatives on the activity of enzyme markers of T-lymphocytes. Cas Lek Cesk 128:1094\u20131097","journal-title":"Cas Lek Cesk"},{"key":"612_CR29","doi-asserted-by":"crossref","unstructured":"Evereklioglu C (2005) Current concepts in the etiology and treatment of Beh\u00e7et\u2019s disease. Surv Ophthalmol 6 (in press)","DOI":"10.1016\/j.survophthal.2005.04.009"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0612-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-005-0612-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0612-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T13:26:31Z","timestamp":1706189191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-005-0612-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,3]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1007\/s00296-005-0612-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,3]]}}}